Logo image of FME.DE

FRESENIUS MEDICAL CARE AG (FME.DE) Stock Fundamental Analysis

Europe - Frankfurt Stock Exchange - FRA:FME - DE0005785802 - Common Stock

40.1 EUR
-0.66 (-1.62%)
Last: 1/2/2026, 5:29:59 PM
Fundamental Rating

5

FME gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 28 industry peers in the Health Care Providers & Services industry. FME has only an average score on both its financial health and profitability. FME is valued quite cheap, while showing a decent growth score. This is a good combination! Finally FME also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

FME had positive earnings in the past year.
In the past year FME had a positive cash flow from operations.
FME had positive earnings in each of the past 5 years.
In the past 5 years FME always reported a positive cash flow from operatings.
FME.DE Yearly Net Income VS EBIT VS OCF VS FCFFME.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

1.2 Ratios

FME has a Return On Assets (2.33%) which is in line with its industry peers.
The Return On Equity of FME (5.55%) is comparable to the rest of the industry.
Looking at the Return On Invested Capital, with a value of 3.95%, FME is doing worse than 60.71% of the companies in the same industry.
FME had an Average Return On Invested Capital over the past 3 years of 3.14%. This is below the industry average of 6.91%.
The 3 year average ROIC (3.14%) for FME is below the current ROIC(3.95%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 2.33%
ROE 5.55%
ROIC 3.95%
ROA(3y)1.65%
ROA(5y)2.29%
ROE(3y)4.06%
ROE(5y)6.04%
ROIC(3y)3.14%
ROIC(5y)4%
FME.DE Yearly ROA, ROE, ROICFME.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

FME has a Profit Margin of 3.66%. This is in the better half of the industry: FME outperforms 60.71% of its industry peers.
FME's Profit Margin has declined in the last couple of years.
FME has a Operating Margin of 7.19%. This is comparable to the rest of the industry: FME outperforms 53.57% of its industry peers.
FME's Operating Margin has declined in the last couple of years.
The Gross Margin of FME (25.00%) is better than 60.71% of its industry peers.
In the last couple of years the Gross Margin of FME has declined.
Industry RankSector Rank
OM 7.19%
PM (TTM) 3.66%
GM 25%
OM growth 3Y-13.44%
OM growth 5Y-12.95%
PM growth 3Y-20.33%
PM growth 5Y-16.53%
GM growth 3Y-3.16%
GM growth 5Y-4.44%
FME.DE Yearly Profit, Operating, Gross MarginsFME.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

5

2. Health

2.1 Basic Checks

FME has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, FME has about the same amount of shares outstanding.
Compared to 5 years ago, FME has less shares outstanding
The debt/assets ratio for FME has been reduced compared to a year ago.
FME.DE Yearly Shares OutstandingFME.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
FME.DE Yearly Total Debt VS Total AssetsFME.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

An Altman-Z score of 2.20 indicates that FME is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.20, FME perfoms like the industry average, outperforming 57.14% of the companies in the same industry.
The Debt to FCF ratio of FME is 5.97, which is a neutral value as it means it would take FME, 5.97 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 5.97, FME is in the better half of the industry, outperforming 78.57% of the companies in the same industry.
FME has a Debt/Equity ratio of 0.73. This is a neutral value indicating FME is somewhat dependend on debt financing.
With a decent Debt to Equity ratio value of 0.73, FME is doing good in the industry, outperforming 67.86% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.73
Debt/FCF 5.97
Altman-Z 2.2
ROIC/WACC0.7
WACC5.67%
FME.DE Yearly LT Debt VS Equity VS FCFFME.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B

2.3 Liquidity

A Current Ratio of 1.36 indicates that FME should not have too much problems paying its short term obligations.
FME has a better Current ratio (1.36) than 67.86% of its industry peers.
FME has a Quick Ratio of 1.36. This is a bad value and indicates that FME is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of FME (1.00) is better than 64.29% of its industry peers.
Industry RankSector Rank
Current Ratio 1.36
Quick Ratio 1
FME.DE Yearly Current Assets VS Current LiabilitesFME.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 16.77% over the past year.
The Earnings Per Share has been decreasing by -6.43% on average over the past years.
Looking at the last year, FME shows a small growth in Revenue. The Revenue has grown by 2.10% in the last year.
The Revenue has been growing slightly by 2.04% on average over the past years.
EPS 1Y (TTM)16.77%
EPS 3Y-1.97%
EPS 5Y-6.43%
EPS Q2Q%34.15%
Revenue 1Y (TTM)2.1%
Revenue growth 3Y3.15%
Revenue growth 5Y2.04%
Sales Q2Q%2.63%

3.2 Future

FME is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.73% yearly.
The Revenue is expected to grow by 4.08% on average over the next years.
EPS Next Y21.73%
EPS Next 2Y12.96%
EPS Next 3Y13.16%
EPS Next 5Y13.73%
Revenue Next Year1.57%
Revenue Next 2Y2.26%
Revenue Next 3Y2.91%
Revenue Next 5Y4.08%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
FME.DE Yearly Revenue VS EstimatesFME.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 5B 10B 15B 20B 25B
FME.DE Yearly EPS VS EstimatesFME.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2 4 6

7

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 10.66, which indicates a very decent valuation of FME.
Based on the Price/Earnings ratio, FME is valued cheaper than 89.29% of the companies in the same industry.
FME's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.51.
The Price/Forward Earnings ratio is 9.67, which indicates a very decent valuation of FME.
Based on the Price/Forward Earnings ratio, FME is valued cheaply inside the industry as 85.71% of the companies are valued more expensively.
FME's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 23.13.
Industry RankSector Rank
PE 10.66
Fwd PE 9.67
FME.DE Price Earnings VS Forward Price EarningsFME.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, FME is valued a bit more expensive than the industry average as 60.71% of the companies are valued more cheaply.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of FME indicates a somewhat cheap valuation: FME is cheaper than 60.71% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 13.41
EV/EBITDA 10.59
FME.DE Per share dataFME.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as FME's earnings are expected to grow with 13.16% in the coming years.
PEG (NY)0.49
PEG (5Y)N/A
EPS Next 2Y12.96%
EPS Next 3Y13.16%

7

5. Dividend

5.1 Amount

FME has a Yearly Dividend Yield of 3.54%.
Compared to an average industry Dividend Yield of 1.47, FME pays a better dividend. On top of this FME pays more dividend than 96.43% of the companies listed in the same industry.
FME's Dividend Yield is rather good when compared to the S&P500 average which is at 2.00.
Industry RankSector Rank
Dividend Yield 3.54%

5.2 History

The dividend of FME has a limited annual growth rate of 0.31%.
Dividend Growth(5Y)0.31%
Div Incr Years1
Div Non Decr Years2
FME.DE Yearly Dividends per shareFME.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

58.83% of the earnings are spent on dividend by FME. This is a bit on the high side, but may be sustainable.
FME's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP58.83%
EPS Next 2Y12.96%
EPS Next 3Y13.16%
FME.DE Yearly Income VS Free CF VS DividendFME.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B
FME.DE Dividend Payout.FME.DE Dividend Payout, showing the Payout Ratio.FME.DE Dividend Payout.PayoutRetained Earnings

FRESENIUS MEDICAL CARE AG

FRA:FME (1/2/2026, 5:29:59 PM)

40.1

-0.66 (-1.62%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-04 2025-11-04/bmo
Earnings (Next)02-24 2026-02-24/amc
Inst Owners43.88%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap23.53B
Revenue(TTM)19.64B
Net Income(TTM)718.19M
Analysts57.93
Price Target47.6 (18.7%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.54%
Yearly Dividend1.19
Dividend Growth(5Y)0.31%
DP58.83%
Div Incr Years1
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.52%
Min EPS beat(2)14.16%
Max EPS beat(2)14.89%
EPS beat(4)4
Avg EPS beat(4)17.81%
Min EPS beat(4)14.16%
Max EPS beat(4)27.17%
EPS beat(8)7
Avg EPS beat(8)16.37%
EPS beat(12)10
Avg EPS beat(12)13.79%
EPS beat(16)12
Avg EPS beat(16)10.84%
Revenue beat(2)0
Avg Revenue beat(2)-2.52%
Min Revenue beat(2)-3.33%
Max Revenue beat(2)-1.71%
Revenue beat(4)2
Avg Revenue beat(4)0.94%
Min Revenue beat(4)-3.33%
Max Revenue beat(4)6.05%
Revenue beat(8)3
Avg Revenue beat(8)-0.62%
Revenue beat(12)4
Avg Revenue beat(12)-0.64%
Revenue beat(16)6
Avg Revenue beat(16)-0.51%
PT rev (1m)-1.72%
PT rev (3m)-5.83%
EPS NQ rev (1m)2.05%
EPS NQ rev (3m)-3.65%
EPS NY rev (1m)2.83%
EPS NY rev (3m)3.37%
Revenue NQ rev (1m)0.31%
Revenue NQ rev (3m)1.16%
Revenue NY rev (1m)0.37%
Revenue NY rev (3m)0.12%
Valuation
Industry RankSector Rank
PE 10.66
Fwd PE 9.67
P/S 1.2
P/FCF 13.41
P/OCF 9.37
P/B 1.82
P/tB N/A
EV/EBITDA 10.59
EPS(TTM)3.76
EY9.38%
EPS(NY)4.15
Fwd EY10.34%
FCF(TTM)2.99
FCFY7.46%
OCF(TTM)4.28
OCFY10.67%
SpS33.47
BVpS22.07
TBVpS-3.21
PEG (NY)0.49
PEG (5Y)N/A
Graham Number43.21
Profitability
Industry RankSector Rank
ROA 2.33%
ROE 5.55%
ROCE 5.62%
ROIC 3.95%
ROICexc 4.26%
ROICexgc 11.65%
OM 7.19%
PM (TTM) 3.66%
GM 25%
FCFM 8.93%
ROA(3y)1.65%
ROA(5y)2.29%
ROE(3y)4.06%
ROE(5y)6.04%
ROIC(3y)3.14%
ROIC(5y)4%
ROICexc(3y)3.31%
ROICexc(5y)4.22%
ROICexgc(3y)8.52%
ROICexgc(5y)10.56%
ROCE(3y)4.51%
ROCE(5y)5.77%
ROICexgc growth 3Y-7.67%
ROICexgc growth 5Y-10.05%
ROICexc growth 3Y-10.35%
ROICexc growth 5Y-11.48%
OM growth 3Y-13.44%
OM growth 5Y-12.95%
PM growth 3Y-20.33%
PM growth 5Y-16.53%
GM growth 3Y-3.16%
GM growth 5Y-4.44%
F-Score5
Asset Turnover0.64
Health
Industry RankSector Rank
Debt/Equity 0.73
Debt/FCF 5.97
Debt/EBITDA 3.12
Cap/Depr 47.15%
Cap/Sales 3.85%
Interest Coverage 3.87
Cash Conversion 83.24%
Profit Quality 244.33%
Current Ratio 1.36
Quick Ratio 1
Altman-Z 2.2
F-Score5
WACC5.67%
ROIC/WACC0.7
Cap/Depr(3y)41.32%
Cap/Depr(5y)47.87%
Cap/Sales(3y)3.79%
Cap/Sales(5y)4.49%
Profit Quality(3y)300.36%
Profit Quality(5y)267.36%
High Growth Momentum
Growth
EPS 1Y (TTM)16.77%
EPS 3Y-1.97%
EPS 5Y-6.43%
EPS Q2Q%34.15%
EPS Next Y21.73%
EPS Next 2Y12.96%
EPS Next 3Y13.16%
EPS Next 5Y13.73%
Revenue 1Y (TTM)2.1%
Revenue growth 3Y3.15%
Revenue growth 5Y2.04%
Sales Q2Q%2.63%
Revenue Next Year1.57%
Revenue Next 2Y2.26%
Revenue Next 3Y2.91%
Revenue Next 5Y4.08%
EBIT growth 1Y-3.43%
EBIT growth 3Y-10.72%
EBIT growth 5Y-11.17%
EBIT Next Year96.22%
EBIT Next 3Y29.78%
EBIT Next 5Y18.68%
FCF growth 1Y-5.89%
FCF growth 3Y1.25%
FCF growth 5Y3.45%
OCF growth 1Y0.06%
OCF growth 3Y-1.4%
OCF growth 5Y-1.45%

FRESENIUS MEDICAL CARE AG / FME.DE FAQ

What is the fundamental rating for FME stock?

ChartMill assigns a fundamental rating of 5 / 10 to FME.DE.


What is the valuation status for FME stock?

ChartMill assigns a valuation rating of 7 / 10 to FRESENIUS MEDICAL CARE AG (FME.DE). This can be considered as Undervalued.


Can you provide the profitability details for FRESENIUS MEDICAL CARE AG?

FRESENIUS MEDICAL CARE AG (FME.DE) has a profitability rating of 4 / 10.


What is the valuation of FRESENIUS MEDICAL CARE AG based on its PE and PB ratios?

The Price/Earnings (PE) ratio for FRESENIUS MEDICAL CARE AG (FME.DE) is 10.66 and the Price/Book (PB) ratio is 1.82.


How sustainable is the dividend of FRESENIUS MEDICAL CARE AG (FME.DE) stock?

The dividend rating of FRESENIUS MEDICAL CARE AG (FME.DE) is 7 / 10 and the dividend payout ratio is 58.83%.